학술논문

Identification of HMGA2 as a predictive biomarker of response to bintrafusp alfa in a phase 1 trial in patients with advanced triple-negative breast cancer
Document Type
Journal
Source
FRONTIERS IN ONCOLOGY; DEC 8 2022, 12 p981940 12p.
Subject
Language
English
ISSN
2234943X